Adimab
Business Services · New Hampshire, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7 Lucent Dr, Lebanon, New Hampshire, 037...Phone Number
(603) 653-5775Website
www.adimab.comRevenue
$21.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Adimab
Adimab is a leading provider of a yeast-based antibody discovery and engineering platform designed to accelerate the development of therapeutic antibodies. The company offers a comprehensive suite of services including antibody discovery, engineering, and multispecific antibody development, aimed at improving patient outcomes. With over 140 biopharma partnerships and a proven track record of advancing therapeutic programs, Adimab is dedicated to supporting its partners through flexible collaboration models. Founded in 2007, Adimab has established itself as a trusted partner in the biopharma industry for the discovery and optimization of antibody therapeutics.Explore more
Adimab Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adimab your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Adimab had a recent Job posting/layoffs
Product Launch: Get notified when Adimab launches new products
Adimab, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Adimab has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Adimab
Check out if Adimab is spiking on competitors!
Earning: See what the market has to say on Adimab recently announced quarterly report
Funding: Get notified immidiatlly once Adimab has new funding data
Recommended Actions
Find VP level buyers at Adimab
Find 3 more new buyers
Compare Similar Companies to Adimab
Compare insights from companies similar to Adimab, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Adimab is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adimab is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adimab.
Adimab financials insights
Gather financial insights about Adimab, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$6M
2010
Series D
$8.2M
Series E
$4M
2012
Series F
$13.8M
Adimab Tech Stack
A closer look at the technologies used by Adimab
See more technologies
Most Recent Scoops
Project
, according to a mid-level source in product development, is in the midst of initiatives related to automated deployment.
Implementation, Product Development, Automation, Product Management, Software
Project
, according to a mid-level source in product development, is in the midst of initiatives related to web development.
Collaboration/Web Apps, Application Development, Product Development, Website, Product Management
Project
, according to a mid-level source in product development, is in the midst of initiatives related to user interface (UI).
Product Development, Product Management, User Interface
Executive Move
Executive Moves, Board of Directors
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Adimab News & Media
Adimab Records Another Year of Double-Digit Clinical Program Growth
– 11 New Clinical Programs in 2025 – – 6 Partner Programs Have Reached the Market – – 89 Total Clinical Programs Initiated to Date – LEBANON, N.H., Jan. 13, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific...Adimab Reports Strong Partnering Year for 2025
– 23 Overall Partnerships in 2025 – – 75 New Programs Added in 2025 – – 50 Milestones Achieved in 2025 – – Generated More Than 650 Total Therapeutic Programs to Date – LEBANON, N.H., Jan. 12, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully...Adimab Provides Update on Pipeline
LEBANON, N.H.--(BUSINESS WIRE)--Adimab provides a pipeline update.Adimab Provides Year-End Update on 2024 Partnership Activities
LEBANON, N.H.--(BUSINESS WIRE)--Adimab provides a year-end update on 2024 partnership activities.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adimab
Sign Up For FreeTo access detailed company insights
Adimab is a leading provider of a yeast-based antibody discovery and engineering platform designed to accelerate the development of therapeutic antibodies. The company offers a comprehensive suite of services including antibody discovery, engineering, and multispecific antibody development, aimed at improving patient outcomes. With over 140 biophar... Read More
